Risultati della ricerca - David Back

Raffina i risultati
  1. 1
    The challenge of HIV treatment in an era of polypharmacy

    The challenge of HIV treatment in an era of polypharmacy di David Back, Catia Marzolini

    Pubblicazione 2020
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Interaction Between Amiodarone and Sofosbuvir-based Treatment for Hepatitis C Virus Infection: Potential Mechanisms and Lessons to be Learned

    Interaction Between Amiodarone and Sofosbuvir-based Treatment for Hepatitis C Virus Infection: Potential Mechanisms and Lessons to be Learned di David Back, David M. Burger

    Pubblicazione 2015
    Testo Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  3. 3
    New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals

    New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals di Kay Seden, David Back, Saye Khoo

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Maraviroc: Pharmacokinetics and drug Interactions

    Maraviroc: Pharmacokinetics and drug Interactions di Sylvie Abel, David Back, Manoli Vourvahis

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes

    Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes di Victoria A. Eagling, John Tjia, David Back

    Pubblicazione 1998
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors

    Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors di Louise Profit, Victoria A. Eagling, David Back

    Pubblicazione 1999
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir

    Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir di Victoria A. Eagling, David Back, Michael Barry

    Pubblicazione 1997
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Darunavir: Pharmacokinetics and Drug Interactions

    Darunavir: Pharmacokinetics and Drug Interactions di David Back, Vanitha Sekar, Richard M. W. Hoetelmans

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid)

    Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid) di Laura Else, Stephen Taylor, David Back, Saye Khoo

    Pubblicazione 2011
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  10. 10
    Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells

    Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells di Philip Martin, R Riley, David Back, Andrew Owen

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications

    Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications di Catia Marzolini, Sara Gibbons, Saye Khoo, David Back

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Differences in the cytochrome <i>P</i>-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 α-ethinyloestradiol. Relative activities of rat and human liver enzymes

    Differences in the cytochrome <i>P</i>-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 α-ethinyloestradiol. Relative activities of rat and human liver enzymes di S. Ball, Lesley M. Forrester, C. Roland Wolf, David Back

    Pubblicazione 1990
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Stopping antiretroviral therapy

    Stopping antiretroviral therapy di Stephen Taylor, Marta Boffito, Saye Khoo, Erasmus Smit, David Back

    Pubblicazione 2007
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  14. 14
    Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

    Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine di Daryl Hodge, David Back, Sara Gibbons, Saye Khoo, Catia Marzolini

    Pubblicazione 2021
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  15. 15
    Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

    Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro di Patrick G. Hoggard, Stephen Kewn, Michael Barry, Saye Khoo, David Back

    Pubblicazione 1997
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients

    Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients di Concepta Merry, Michael Barry, Fiona Mulcahy, Kathryn L. Halifax, David Back

    Pubblicazione 1997
    Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  17. 17
    Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine

    Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine di Beth Williamson, Kelly E. Dooley, Yuan Zhang, David Back, Andrew Owen

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz

    The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz di S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

    Pubblicazione 2001
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users

    Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users di S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

    Pubblicazione 2001
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect

    Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect di Felix Stader, Saye Khoo, Marcel Stoeckle, David Back, Hans H. Hirsch, Manuel Battegay, Catia Marzolini

    Pubblicazione 2020
    Testo Testo
    Carta
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: